CV Technologies was the company involved in the CMAJ article.
They have a product containing ginseng extract that is sold widely to ward off the common cold and flu. It is called COLD-fX. This is their web site:
cvtechnologies.com
This is the stock symbol - CVQ.V:
finance.yahoo.com
Note the continual rise from Jan/03 at pennies to $4 today. Thanks to ginseng!
This is the relevant US patent involved:
United States Patent 6,432,454
Shan , et al. August 13, 2002
Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
Abstract
The invention is directed to chemical processes of preparing fractions from North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
Inventors: Shan; Jacqueline J. (Edmonton, CA); Pang; Peter K. T. (Edmonton, CA); Huang; Buhan (Edmonton, CA); Ling; Lei (Edmonton, CA)
Assignee: C. V. Technologies, Inc. (Edmonton, CA)
Appl. No.: 581161
Filed: July 27, 2000
PCT Filed: November 11, 1998
PCT NO: PCT/US90/25724
patft.uspto.gov |
